Yoshio Nakamura, et al. “Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1).” BMC Cancer, 2026. doi:10.1186/s12885-026-15829-2.
@article{Nakamura2026,
title = {Nivolumab for unresectable cutaneous epithelial malignancies: an open-label, single-arm, multi-centre, phase II trial (NMSC-PD1)},
author = {Nakamura, Yoshio and Yamazaki, Naoya and Namikawa, Kenjiro and Uchi, Hiroshi and Mori, Shoichiro and Ogawa-Momohara, Mariko and Fujimura, Taku and Takenouchi, Tatsuya and Kurimoto, Mana and Yamamoto, Yuki and Otsuka, Atsushi and Kabashima, Kenji and Fusumae, Takayuki and Hirai, Ikuko and Tanese, Keiji and Saito, Yasuko and Amagai, Masayuki and Takemura, Ryo and Sato, Yasunori and Funakoshi, Takeru},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-15829-2},
url = {https://doi.org/10.1186/s12885-026-15829-2}
}